Pregled bibliografske jedinice broj: 367749
Screening of potential prodrugs on cells derived from Dupuytren’s disease patients
Screening of potential prodrugs on cells derived from Dupuytren’s disease patients // Biomedicine & pharmacotherapy, 63 (2009), 8; 577-585 doi:10.1016/j.biopha.2008.10.005 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 367749 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Screening of potential prodrugs on cells derived from Dupuytren’s disease patients
Autori
Kraljević Pavelić, Sandra ; Bratulić, Siniša ; Hock, Karlo ; Jurišić, Davor ; Hranjec, Marijana ; Karminski-Zamola, Grace ; Žinić, Biserka ; Bujak, Maro ; Pavelić, Krešimir
Izvornik
Biomedicine & pharmacotherapy (0753-3322) 63
(2009), 8;
577-585
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Dupuytren's contracture ; fibroblasts ; myofibroblasts
Sažetak
Dupuytren’s Disease (DD) is a fibroproliferative disorder, the cure for which is still limited to surgical excision of the affected fascia, often leading to high recurrence rates. Due to this fact, non-surgical treatments are being investigated, among them those targeting molecular processes of proliferation and differentiation in Dupuytren’ s cell cultures. Drugs with antiproliferative action may be valuable in DD treatment. Through characterization of changes on DD-specific cells, we therefore decided to test the therapeutic potential of new cytostatic drugs for DD treatment and/or for reduction of post-operative recurrence rates. The N-sulphonylpyrimidine derivative, amidino-substituted benzimidazo[1, 2-a]quinoline, and amidino dihydrothienothienyl[2, 3-c]quinolone hydrochloride, known to affect proliferation processes, were tested for their antiproliferative activity on primary fibroblasts/myofibroblasts cell cultures derived from the palmar fascia of patients with DD. Only amidino dihydrothienothienyl[2, 3-c]quinolone hydrochloride acted in a highly specific manner on cells derived from diseased fascia of DD patients and exhibited a low cytotoxic effect. This result might be a consequence of its specific activity on cytoskeleton changes occurring in differentiating cells. A similar short-term differential antiproliferative effect was observed by the N-sulphonylpyrimidine derivative that was however completely lost after 6- and 14-day treatments. The amidino-substituted benzimidazo[1, 2-a]quinoline exerted a strong non-specific, dose-related antiproliferative activity on cell types.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
14V09809
MZOS-098-0982914-2935 - Sinteza novih biološki aktivnih derivata nukleobaza i nukleotida (Žinić, Biserka, MZOS ) ( CroRIS)
MZOS-125-0982464-1356 - Novi heterocikli kao antitumorski i antivirusni (pametni) lijekovi (Hranjec, Marijana, MZOS ) ( CroRIS)
098-0982464-2393 - Molekularna obilježja miofibroblasta Dupuytrenove bolesti
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Fakultet kemijskog inženjerstva i tehnologije, Zagreb,
Klinički bolnički centar Rijeka
Profili:
Sandra Kraljević Pavelić
(autor)
Maro Bujak
(autor)
Grace Karminski-Zamola
(autor)
Biserka Žinić
(autor)
Krešimir Pavelić
(autor)
Karlo Hock
(autor)
Siniša Bratulić
(autor)
Davor Jurišić
(autor)
Marijana Hranjec
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- CA Search (Chemical Abstracts)